Written by: Ricardo Zwirtes, MD Vice President of Clinical Development, SQZ Biotechnologies As we continue to search for more effective treatments for head and neck cancers, cell therapy is an exciting...
Written by Dan P. Zandberg, MD Squamous cell carcinoma is the most common cancer that originates in the head and neck. The most frequent primary sites of origin in the United...
Written by Wey-Wey Kwok, JD The Center for Medicare Advocacy (CMA) is a non-profit, public interest law organization headquartered in Connecticut and Washington, D.C., that works to advance access to comprehensive...
Written by Ron J. Karni, MD Head and neck cancer patients are experiencing increasing rates of survivorship. This also means many patients are living with the side effects of head and...
Written by Marshall Posner, MD & Eric Genden, MD, MHCA, FACS A large shift in the causes and natural history of head and neck cancer has radically changed the prognosis and...
